Astragaloside IV is a potential natural neuroprotective agent for stroke: a review
Frontiers in Pharmacology · 21.01.2026 · 16
DOI: 10.3389/fphar.2025.1718700 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 21.01.2026. Verfasst von Qiao-Li Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, The Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, Gansu, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Gansu Province, Natural Science Foundation of Gansu Province.
Themen: Schlaganfall
Abstract (Originalsprache)
Stroke poses a severe threat to human health, with limited therapeutic options currently available. Astragaloside IV (AS-IV), a primary bioactive metabolite derived from Astragalus membranaceus, exhibits multifaceted pharmacological effects, including anti-inflammatory, anti-fibrotic, and antioxidative properties. This review systematically examines recent advances in AS-IV research for stroke treatment, detailing its sources, physicochemical characteristics, mechanisms of action, and therapeutic efficacy in both in vitro and in vivo models. We critically analyze the potential of AS-IV as an adjunctive therapy for stroke, addressing current research hotspots, challenges, and emerging strategies. Notably, AS-IV synergistically enhances neuroprotection when combined with other plant-derived metabolites. This work provides a theoretical foundation for further development of AS-IV in stroke management. In summary, AS-IV demonstrates significant promise as a natural neuroprotective agent worthy of continued exploration for adjuvant stroke therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, The Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
- College of Acupuncture and Massage, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
- Department of Acupuncture and Moxibustion, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
- Acupuncture Department, The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Förderung
- Science and Technology Department of Gansu Province
- Natural Science Foundation of Gansu Province
Zitieren
APA
Zhang, Q. L., Qin, W. X., Li, X. J., Zhang, Y. B., Li, M., Xu, J. F., & Mao, Z. N. (2026). Astragaloside IV is a potential natural neuroprotective agent for stroke: a review. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1718700
Vancouver
Zhang QL, Qin WX, Li XJ, Zhang YB, Li M, Xu JF, et al. Astragaloside IV is a potential natural neuroprotective agent for stroke: a review. Frontiers in Pharmacology. 2026;16. doi:10.3389/fphar.2025.1718700
BibTeX
@article{Zhang2026,
author = {Zhang, Qiao-Li and Qin, Wen-Xiu and Li, Xiu-Juan and Zhang, Yun-Bo and Li, Ming and Xu, Jun-Feng and Mao, Zhong-Nan},
title = {Astragaloside IV is a potential natural neuroprotective agent for stroke: a review},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {16},
doi = {10.3389/fphar.2025.1718700}
}
EUVIMED